Greenlight Capital TEVA trades
David Einhorn
David Einhorn TEVA PHARMACEUTICAL IND LTD stake
total: 364
Trades details
- Total transactions:
- 1
- New positions:
- 1
- Held for:
- 0 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, David Einhorn holds 1,817,146 TEVA PHARMACEUTICAL IND LTD (TEVA) shares with a market value of roughly $71.96M accounting for 2.03% of the overall portfolio. Greenlight Capital first purchased TEVA in 2026 Q3, initially acquiring about 1.82M shares.
When did David Einhorn buy TEVA PHARMACEUTICAL IND LTD (TEVA)?
David Einhorn first invested in TEVA PHARMACEUTICAL IND LTD (TEVA) in 2026 Q3 at the reported quarter-end price of $39.60 per share.
David Einhorn's historical trades in TEVA PHARMACEUTICAL IND LTD
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
2.03%
|
1,817,146
|
$39.60
|
$71,958,981
|
new
|
+2.03%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.